Lantern Pharma Inc (LTRN)
Healthcare
Biotechnology
2.60 $
-0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Lantern Pharma Inc (LTRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -1.3 | -2.1 | -5.7 | -11 | -13 | -14 | -18 | -16 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | |
| 0.2 | 0.1 | 1.2 | 1.0 | 1.2 | 1.1 | 0.7 | 0.7 | |
| 0.2 | 0.1 | 1.2 | 1.2 | 1.7 | – | – | – | |
| 0.3 | 0.2 | -0.9 | 0.6 | -0.6 | 0.5 | 2.2 | 0.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | -20 | 0.2 | -0.9 | 3.4 | 11 | |
| – | 2.9 | 26 | -0.9 | -2.5 | -0.5 | – | – | |
| 0.1 | 0.1 | 0.1 | 0.0 | – | – | – | – | |
| 0.5 | 2.9 | 24 | 63 | -2.2 | -0.5 | 0.1 | 1.5 | |
| -0.7 | 0.8 | 18 | 33 | -15 | -16 | -14 | -3.1 | |
| -1.3 | -2.1 | -5.7 | -11 | -13 | -14 | -18 | -16 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.